Article
Treatment patterns, clinical outcomes and gene mutation characteristics of hepatitis B virus-associated mantle cell lymphoma.
Hematological oncology - 1 May 2024
Feng Jiangfang, Fei Yue, Gao Meng, Meng Xiangrui, Zeng Dongfeng, Zou Dehui, Ye Haige, Liang Yun, Sun Xiuhua, Liang Rong, Zhou Hui, Wang Xianhuo, Zhang Huilai
Abstract excerpt
Mantle cell lymphoma (MCL) is an uncommon and incurable B-cell lymphoma subtype that has an aggressive course. Hepatitis B virus (HBV) infection has been associated with an increased risk for B-cell lymphomas, and is characterized by distinct clinical and genetic features. Here, we showed that 9.5% of MCL Chinese patients were hepatitis B surface antigen positive (HBsAg+). Compared to HBsAg-negative (HBsAg-)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
